Breeze Acquisition II Units (BREZU) last traded on June 10, 2026. A Form 25-NSE filed on June 10, 2026 removes its shares from exchange listing.
What Changed
Price Move History
- Daily moves over 5%
- 0 19 sessions, May 13, 2026 to June 10, 2026
- Largest daily move
- +0.3% close of June 10, 2026
Company Description
Breeze Acquisition II Units (BREZU) is classified in the shell companies industry within the Financial Services sector.
BREZU gained 0.6% in the week to June 10, 2026. The last closing price was $10.11.
This page collects what Stock Titan holds for BREZU, including price data, latest news, SEC filings, and short interest trends.
Stock Performance
Breeze Acquisition II Units (BREZU) closed at $10.11 on June 10, 2026. In the week to June 10, 2026, the price gained 0.6%.
BREZU Metrics & Rankings
Price returns through June 10, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Breeze Acquisition II Units has 1 recent news article. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. View all BREZU news →
SEC Filings
Breeze Acquisition II Units has filed 3 recent SEC filings, including 1 Form NT 10-Q, 1 Form 25-NSE, 1 Form 8-K. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BREZU SEC filings →
Short Interest History
Short interest in Breeze Acquisition II Units (BREZU) currently stands at 7.3 thousand shares, up 260.4% from the previous reporting period. Since May 2026, short interest has increased by 260.4%.
Days to Cover History
Days to cover for Breeze Acquisition II Units (BREZU) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
BREZU Company Profile & Sector Positioning
Breeze Acquisition II Units (BREZU) operates in the Shell Companies industry within the broader Financial Services sector.
Investors comparing BREZU often look at related companies in the same sector, including Drugs Made In America Acquisition II Corp. (DMII), Churchill Capital Corp XI (CCXI), EQV Ventures Acquisition Corp. II (EVAC), Bain Capital GSS Investment Corp. (BCSS), and Cantor Equity Partners IV, Inc. (CEPF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BREZU's relative position within its industry.